Inhalation adjuvant therapy for lung cancer

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 23, Issue 4, 2010, Pages 181-187

  Yi, Dandan ^a   Wiedmann, Timothy Scott ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MedDiscerna   (United States)

Author keywords

adjuvant therapy; chemoprevention; chemotherapy; inhalation; lung cancer

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CISPLATIN; EFLORNITHINE; FLUOROURACIL; OLTIPRAZ; POLYPHENON E;

ADENOCARCINOMA; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG FORMULATION; HUMAN; LUNG CANCER; NONHUMAN; REVIEW; SEX DIFFERENCE;

ADENOCARCINOMA; ADMINISTRATION, INHALATION; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOPREVENTION; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; RESPIRATORY THERAPY;

EID: 77955452827     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2009.0787     Document Type: Review

References (56)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71-96.
2. Society AC. American Cancer Society, http:///www.cancer .org, 2009.
3. Vineis P, Hoek G, Krzyzanowski M, Vigna-Taglianti F, Veglia F, Airoldi L, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund EE, Agudo A, Martinez C, Dorronsoro M, Barricarte A, Cirera L, Quiros JR, Berglund G, Manjer J, Forsberg B, Day NE, Key TJ, Kaaks R, Saracci R, Riboli E: Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study. Environ Health. 2007;6:7.
4. Yang L, Parkin DM, Ferlay J, Li L, Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev. 2005;14:243-250.
5. Gagnadoux F, Hureaux J, Vecellio L, Urban T, Le Pape A, Valo I, Montharu J, Leblond V, Boisdron-Celle M, Lerondel S, Majoral C, Diot P, Racineux JL, Lemarie E: Aerosolized chemotherapy. J Aerosol Med Pulm Drug Deliv. 2008;21:61-70.
6. Gautam A: Targeted delivery of therapeutics by aerosol for cancer of the lung. Curr. Cancer Drug Targets. 2003;3:57.
7. Rao RD, Markovic SN, Anderson PM: Aerosol therapy for malignancy involving the lungs. Curr Cancer Drug Targets. 2008;3:239-250.
8. Franklin WA: Molecular and Cellular Pathology of Lung Cancer. Philadelphia, PA: Lippincott Williams & Wilkins; pp. 231- 260, 2005.
9. Lynch TJ, Bogart JA, Curran WJ Jr, DeCamp MM, Gandara DR, Goss G, Henschke CI, Jett JR, Johnson BE, Kelly KL, Le Chevalier T, Mulshine JL, Scagliotti GV, Schiller JH, Shaw A, Thatcher N, Vokes EE, Wood DE, Hart C: Early stage lung cancer-new approaches to evaluation and treatment: conference summary statement. Clin Cancer Res. 2005;11(13 Pt 2):4981s-4983s.
10. Network NCC. National Comprehensive Cancer Network, http:///www.org, 2009
11. Bar J, Herbst RS, Onn A: Targeted drug delivery strategies to treat lung metastasis. Expert Opin Drug Deliv. 2009;6:1003-1016.
12. Koshkina NV, Waldrep JC, Knight V: Camptothecins and lung cancer: improved delivery systems by aerosol. Curr Cancer Drug Targets. 2003;3:251-264.
13. Skubitz KM, Anderson PM: Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial. Anti-Cancer Drugs. 2009;11:555-563.
14. Tatsumura T, Koyama S, Tsujimoto M, Kitagawa M, Kagamimori S: Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical. Br J Cancer. 1993;68:1146-1149.
15. Xie Y, Zeng P, Wiedmann TS: Disease guided optimization of the respiratory delivery of microparticulate formulations. Expert Opin Drug Deliv. 2008;5:269-289.
16. Cancer Co. National Cancer Data Base. Chicago, IL: American College of Surgeons; 2006.
17. Society AC: Cancer Facts and Figures. Chicago, IL: American Cancer Society; 2009.
18. Wittgen BP, Kunst PW, van der Born K, van Wijk AW, Perkins W, Pilkiewicz FG, Perez-Soler R, Nicholson S, Peters GJ, Postmus PE: Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clin Cancer Res. 2007;13:2414-2421.
19. Molina JR YP, Cassivi SD, Schild SE, Adjei AA: Non-small cell lung cancer: epidemiology, risk factors, treatment and survivorship. Mayo Clin Proc. 2008;83:584-594.
20. Debrix I, Avenin D, Andre T, Abbas F, Gligorov J, Milleron B, Lotz JP, Becker A: [Anticancer chemotherapy in the elderly: a review of the literature]. Bull Cancer. 2008;95:2008; F37-F43.
21. Mulshine JL, Cuttitta F, Tockman MS, De Luca LM. Lung cancer evolution to preinvasive management. Clin Chest Med. 2002;23:37-48.
22. Chhatwani L, Cabebe E, Wakelee HA: Adjuvant treatment of resected lung cancer. Proc Am Thorac Soc. 2009;6:194-200.
23. Wiedmann TS, Wattenberg LW: Chemoprevention of cancer of the respiratory tract by agents delivered by aerosol: Applications to glucocorticoids and 5-fluorouracil. Cancer Chemoprevent. 2004;1:153-167.
24. Younis T, Al-Fayea T, Virik K, Morzycki W, Saint-Jacques N: Adjuvant chemotherapy uptake in non-small cell lung cancer. J Thorac Oncol. 2008;3:1272-1278.
25. Haigentz M Jr, Perez-Soler R: Chemopreventive therapeutics: inhalation therapies for lung cancer and bronchial premalignancy. Methods Mol Med. 2003;75:771-780.
26. Koshkina NV, Golunski E, Roberts LE, Gilbert BE, Knight V: Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice. J Aerosol Med. 2004;17:7-14.
27. Koshkina NV, Kleinerman ES: Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases. Int J Cancer. 2005;116:458-463.
28. Koshkina NV, Kleinerman ES, Waldrep C, Jia S-F, Worth LL, Gilbert BE, Knight V: 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin Cancer Res. 2000;6:2876-2880.
29. Otterson GA, Villalona-Calero MA, Sharma S, Kris MG, Imondi A, Gerber M, White DA, Ratain MJ, Schiller JH, Sandler A, Kraut M, Mani S, Murren JR: Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs. Clin Cancer Res. 2007;13:1246-1252.
30. Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, Cormier Y, Goss G, Inculet R, Vallieres E, Fry W, Bethune D, Ayoub J, Ding K, Seymour L, Graham B, Tsao MS, Gandara D, Kesler K, Demmy T, Shepherd F: Vinorelbine plus cisplatin vs. observation in resected non-smallcell lung cancer. N Engl J Med. 2005;352:2589-2597.
31. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350:351-360.
32. Belani CP: The ANITA trial seals the deal for adjuvant therapy in non-small-cell lung cancer. Clinical Lung Cancer. 2005;6:331-332.
33. Waller D, Peake MD, Stephens RJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG: Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg. 2004;26:173-182.
34. Scagliotti GV, Fossati R, Torri V, Crino L, Giaccone G, Silvano G, Martelli M, Clerici M, Cognetti F, Tonato M: Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst. 2003;95:1453-1461.
35. Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, Adjuvant Navelbine International Trialist A: Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA nonsmall- cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J RadiatOncol Biol Phys. 2008;72:695-701.
36. Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, Dunant A, Torri V, Rosell R, Seymour L, Spiro SG, Rolland E, Fossati R, Aubert D, Ding K, Waller D, Le Chevalier T: Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26:3552-3559.
37. Nakagawa M, Tanaka F, Tsubota N, Ohta M, Takao M, Wada H: A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)-the 4th study. Ann Oncol 2005;16:75-80.
38. Hershey AE, Kurzman ID, Forrest LJ, Bohling CA, Stonerook M, Placke ME, Imondi AR, Vail DM: Inhalation chemotherapy for macroscopic primary or metastatic lung tumors: proof of principle using dogs with spontaneously occurring tumors as a model. Clin Cancer Res. 1999;5:2653-2659.
39. Koshkina NV, Gilbert BE, Waldrep JC, Seryshev A, Knight V: Distribution of camptothecin after delivery as a liposome aerosol or following intramuscular injection in mice. Cancer Chemother Pharmacol. 1999;44:187-192.
40. Latimer P, Simmons-Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K: Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases. Exp Biol Med (Maywood). 2009;234:1244-1252.
41. Zou Y, Fu H, Ghosh S, Farquhar D, Klostergaard J: Antitumor activity of hydrophilic paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models. Clin Cancer Res. 2004;10:7382-7391.
42. Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR: Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol. 2008;26:5043-5051.
43. Estensen RD, Jordan MM, Wiedmann TS, Galbraith AR, Steele VE, Wattenberg LW: Effect of chemopreventive agents on separate stages of progression of benzo[a]pyrene induced lung tumors in A/J mice. Carcinogenesis. 2004; 25:197-201.
44. Wattenberg LW, Wiedmann TS, Estensen RD: Chemoprevention of cancer of the upper respiratory tract of the Syrian golden hamster by aerosol administration of difluoromethylornithine and 5-fluorouracil. Cancer Res. 2004;64:2347-2349.
45. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Galbraith AR, Steele VE, Kelloff GJ: Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myoinositol. Carcinogenesis. 2000;21:179-182.
46. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, Kelloff GJ: Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res. 1997;57:5489-5492.
47. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Steele VE, Kelloff GJ: Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res. 1997;57:5489-5492.
48. Wattenberg LW, Wiedmann TS, Estensen RD, Zimmerman CL, Galbraith AR, Steele VE, Kelloff GJ: Chemoprevention of pulmonary carcinogenesis by brief exposures to aerosolized budesonide or beclomethasone dipropionate and by the combination of aerosolized budesonide and dietary myoinositol. Carcinogenesis. 2000;21:179-182.
49. Sharma S, Gao P, Steele VE: The chemopreventive efficacy of inhaled oltipraz particulates in the B[a]P-induced A/J mouse lung adenoma model. Carcinogenesis. 2006;27:1721-1727.
50. Dahl AR, Grossi IM, Houchens DP, Scovell LJ, Placke ME, Imondi AR, Stoner GD, De Luca LM, Wang D, Mulshine JL: Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study. Clin Cancer Res. 2000;6:3015-3024.
51. Yan Y, Cook J, McQuillan J, Zhang G, Hitzman CJ, Wang Y, Wiedmann TS, You M: Chemopreventive effect of aerosolized polyphenon E on lung tumorigenesis in A/J mice. Neoplasia. 2007;9:401-405.
52. Wang Y, Zhang Z, Yan Y, Lemon WJ, LaRegina M, Morrison C, Lubet R, You M: A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility. Cancer Res. 2004;64:1647-1654.
53. Estensen RD, Anderson WR, Galbraith AR, Hartle DE, Jordan MM, Ondrey FG, Wattenberg LW: A method of producing carcinoma in upper aerodigestive tree and esophagus of the Syrian golden hamster using wounding and instillation of N-methylnitrosourea. Cancer Epidemiol Biomarkers Prev. 2007;16:1644-1650.
54. Huland E, Heinzer H, Aalamian M, Huland H: New applications of cytokines: inhalation of interleukin-2 to control pulmonary metastases. renal, bladder, prostate and testicular cancer: an update. In: Proceedings of the Congress on Progress and Controversies in Oncological Urology, 6th ed., Rotterdam, The Netherlands, Oct. 2000; 65-74, 2001.
55. Lam S, leRiche JC, McWilliams A, Macaulay C, Dyachkova Y, Szabo E, Mayo J, Schellenberg R, Coldman A, Hawk E, Gazdar A: A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Clin Cancer Res. 2004;10:6502-6511.
56. Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, Au DH: Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:712-719.